BioNeutra Global Corporation
BioNeutra Global Corporation
Your view on BGACF
Overview
What the company does, where it operates, and who runs it.
About BioNeutra Global Corporation
- Industry
- Packaged Foods
- Sector
- Consumer Defensive
- CEO
- Jianhua Zhu
- Headquarters
- 9608 - 25 Avenue NW, Vancouver, AB, CA
- Industry
- Packaged Foods
- Sector
- Consumer Defensive
- CEO
- Jianhua Zhu
- Headquarters
- 9608 - 25 Avenue NW, Vancouver, AB, CA
BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods, and beverages with a focus on oligosaccharides.
The company's lead product is VitaFiber, an isomalto-oligosaccharide functional and health food ingredient that offers low calorie soluble prebiotic fiber for human digestive health. It serves small and medium enterprises, and various food manufacturers in in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia.
The company provides VitaFiber through Amazon.com and Shopify.com, as well as other direct-to-consumer retail channels. BioNeutra Global Corporation is based in Edmonton, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for BioNeutra Global Corporation, and the rating behind it. BGACF last traded at $0.0056; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for BioNeutra Global Corporation. Starting points for BioNeutra Global Corporation: EPS -$0.05, beta 1.09 — an Packaged Foods name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for BioNeutra Global Corporation. BioNeutra Global Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for BioNeutra Global Corporation. Trailing twelve-month EPS for BioNeutra Global Corporation stands at -$0.05. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for BioNeutra Global Corporation. BioNeutra Global Corporation has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
BioNeutra Global Corporation valued side by side against its closest peers. BioNeutra Global Corporation is measured against Packaged Foods peers within the Consumer Defensive sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold BioNeutra Global Corporation, and how their positions are changing. At a $260,113 market value, institutional positions materially move BioNeutra Global Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by BioNeutra Global Corporation executives and directors. Shares of BioNeutra Global Corporation have traded between $0.0056 and $0.07 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming BioNeutra Global Corporation. BioNeutra Global Corporation is a $260,113 Consumer Defensive company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming BioNeutra Global Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for BioNeutra Global Corporation. Coverage tracks BioNeutra Global Corporation within Packaged Foods (Consumer Defensive). Press releases and market coverage, newest first.